FDA OKs First Drug Targeting NRG1 Gene Fusion in Pancreatic, Lung Cancers

Retrieved on: 2024-12-04 22:28:15

Tags for this article:

Click the tags to see associated articles and topics

FDA OKs First Drug Targeting NRG1 Gene Fusion in Pancreatic, Lung Cancers. View article details on hiswai:

Excerpt

... FDA APPROVED zenocutuzumab-zbco (Bizengri) over a computer rendering of monoclonal antibodies attacking. The FDA ...

Article found on: www.medpagetoday.com